Aurion Biotech

Developer of regenerative cell therapies for ocular diseases

placeSeattle, Washington, United States calendar_todayFounded 2021 groups46 employees language aurionbiotech.com

Social engagement

Social engagement: 10.1K social following, 8 posts in the last 12 months — around the industry typical range.

Investor mix

7 investors on record; lead investors include Deerfield.

Investor typeCountShare
Venture capital229%
Private equity229%
Bank & private debt114%
Other / undisclosed229%

Recent activity

23 Jun 2026
Event
SICSSO - International Society of Cornea, Stem Cells and Ocular Surface 2026 Congress
11 Jun 2026
Event
AECOS 2026 (American-European Congress of Ophthalmic Surgery)
10 Jun 2026
Event
AECOS 2026
Coming soon